Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy
Clinical trial NCT03670056 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03670056
- Sponsor
- Yale University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2025-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.